Investors & Media

Transformative science, targeted medicines

We are working to advanceĀ a deep pipeline of precision therapies, designed to allow patients to live longer, better lives. Our approach combines world-leading expertise in protein kinases with sound execution and an intense focus on discovery.

SEC Filings

SEC Filings

Filing date Form Description View
10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML EX-101.INS - EX-101.INS
10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML EX-101.INS - EX-101.INS
10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML EX-101.INS - EX-101.INS
10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML EX-101.INS - EX-101.INS
10-K/A

Amendment to a previously filed 10-K

View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML EX-101.INS - EX-101.INS
10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML EX-101.INS - EX-101.INS
10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML EX-101.INS - EX-101.INS
10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML EX-101.INS - EX-101.INS
10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML EX-101.INS - EX-101.INS

Pagination